Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Frontiers in Immunology|June 20, 2022
Antibody Response to COVID-19 Booster Vaccination in Healthcare WorkersArianna Pani, Alessandra Romandini, Alice Schianchi, et al.
Plos One|September 8, 2020
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patientsClaudia Alteri, Valeria Cento, Maria Antonello, et al.
Antiviral Therapy|September 13, 2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysisMassimo Puoti, Alessandro Cozzi-Lepri, Giuseppe Paraninfo, et al.
Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Plos One|February 23, 2021
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational studySalvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre studyMichele Bartoletti, Lorenzo Marconi, Luigia Scudeller, et al.
Scientific Reports|January 26, 2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access programVincenza Calvaruso, Chiara Mazzarelli, Laura Milazzo, et al.
The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infectionNezam Afdhal, Stefan Zeuzem, Paul Kwo, et al.
Pageof 24